A federal appeals court has handed Berkshire Hathaway-affiliated insurers a win in a half-billion-dollar asbestos-talc bankruptcy fight.
In a precedential opinion filed on April 27, 2026, the United States Court of Appeals for the Third Circuit ruled that Whittaker, Clark & Daniels, Inc. and three affiliated companies properly entered Chapter 11 bankruptcy, and that successor liability claims asserted by asbestos-talc tort claimants belong to the debtors' bankruptcy estates rather than to the individual plaintiffs. The decision paves the way for a roughly $535 million settlement with Brenntag, the chemicals distributor that purchased the debtors' operating assets more than two decades ago.
The case matters to the insurance industry because of who is standing behind the debtors. National Indemnity Company, a Berkshire Hathaway subsidiary, acquired the debtors' parent companies years after the 2004 asset sale, later assigning its acquisition rights to fellow Berkshire affiliate Ringwalt & Liesche Co., which remains the debtors' ultimate parent. Through a chain of indemnity agreements, National Indemnity currently backstops certain asbestos-related successor liability claims against Brenntag. A group of Berkshire-affiliated entities including National Indemnity, National Liability & Fire Insurance Company, Columbia Insurance Company, and Resolute Management, Inc., among others, appeared in the appeal as intervenor-appellees.
The story begins with talc. Whittaker and its affiliates manufactured, processed, stored, and distributed industrial chemicals and minerals, including asbestos-laden talc, for years. Their products triggered a wave of personal injury claims from consumers who developed mesothelioma. Environmental contamination claims were also brought, spanning at least fourteen states.
In 2004, Whittaker and two affiliates sold substantially all of their operating assets to Brenntag subsidiaries for approximately $200 million. A key feature of the deal was that Brenntag expressly excluded all pre-sale asbestos and environmental liabilities. The sellers, in turn, agreed to indemnify Brenntag for any such liabilities that might attach to it. After the sale, the debtors continued to exist as shell companies holding limited assets to satisfy their pending and future tort claims.
Things escalated in March 2023 when a South Carolina jury awarded plaintiff Sarah Plant $29 million after she was diagnosed with mesothelioma from exposure to Whittaker's asbestos-contaminated talc. Days later, the South Carolina court placed Whittaker into receivership and appointed Peter Protopapas as receiver.
Whittaker's board did not wait. Without consulting the receiver, it passed a resolution and filed Chapter 11 petitions in New Jersey. The receiver moved to dismiss the filing, arguing the receivership order had stripped the board of any authority to petition for bankruptcy. The Bankruptcy Court disagreed, and the District Court affirmed.
Meanwhile, with roughly 2,700 plaintiffs asserting asbestos claims and few assets left after the 2004 sale, the debtors turned their successor liability claims against Brenntag into leverage. The result was a settlement valued at approximately $535 million, in exchange for, among other terms, a release of all successor liability claims against Brenntag.
There was a catch. A group of talc claimants, represented by the Official Committee of Talc Claimants, had already asserted their own successor liability claims against Brenntag before the bankruptcy. They argued those claims, particularly those based on a "product-line" theory of liability recognized in a handful of states including New Jersey and California, belonged to them individually and not to the bankruptcy estate. If the Committee prevailed, those claimants could have pursued Brenntag separately, outside the bankruptcy process, potentially diverting value from the estate and the settlement.
The Third Circuit shut that door. Writing for the panel, Circuit Judge Ambro held that the South Carolina receivership order did not reach Whittaker's corporate affairs. Under New Jersey law, where Whittaker is incorporated, the receiver would have needed to seek recognition in New Jersey and the appointment of an ancillary receiver to displace the board. That never happened. The court also flagged constitutional concerns, noting that letting one state's court seize control of a corporation governed by another state's laws would represent an unprecedented overreach in the federal system.
On the estate-property question, the court applied its earlier rulings to conclude that the product-line claims are derivative of harm to the debtors, not personal to individual tort claimants. The theory of successor liability turns on Brenntag's relationship with the original manufacturer, not on any individual plaintiff's asbestos exposure. The court found the claims functionally similar to fraudulent transfer claims, which are well established as estate property. Allowing individual creditors to peel off and pursue those claims in state courts, the court reasoned, would undermine orderly distribution of estate assets.
For insurers and indemnitors managing legacy asbestos books, the ruling carries practical significance. By channeling successor liability claims into the bankruptcy estate, the decision consolidates the universe of claims that an indemnitor like National Indemnity must account for. The $535 million settlement, once approved, would resolve successor liability exposure in a single transaction rather than across individual state-court actions. That kind of certainty is what runoff carriers and legacy-liability managers look for when pricing and reserving long-tail exposures.
The decision also reinforces a pattern in mass-tort bankruptcies. Courts have shown a willingness to treat successor liability claims as estate property, which means debtors and their insurer-affiliated parents can negotiate global settlements with greater confidence that individual creditors will not be able to pursue those same claims in parallel litigation.